Stock Screener App

Frei -

Installieren

3.27

0.91% -0.03

after-market

Handel nachbörslich: 3.27

Acumen Pharmaceuticals Inc (ABOS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Acumen Pharmaceuticals Inc-Aktie (ABOS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	36.50% 26.51	41.75	30.37	39.60	32.27
Operating Income/Loss	36.50% -26.51	-41.75	-30.37	-39.60	-32.27
Nonoperating Income/Loss	92.25% 0.062	0.80	1.574	2.443	2.50
Income/Loss From Continuing Operations Before Tax	35.41% -26.45	-40.95	-28.80	-37.15	-29.77
Income/Loss From Continuing Operations After Tax	35.41% -26.45	-40.95	-28.80	-37.15	-29.77
Net Income/Loss	35.41% -26.45	-40.95	-28.80	-37.15	-29.77
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.00% 60.57	60.57	60.53	0.0224	60.08
Diluted Average Shares	0.00% 60.57	60.57	60.53	0.0224	60.08
Basic Earnings Per Share	35.29% -0.44	-0.68	-0.48	-0.62	-0.50
Diluted Earnings Per Share	35.29% -0.44	-0.68	-0.48	-0.62	-0.50
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters